chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blood pressure was 139/85; heart rate went up to 120 /5 times within an hour/heart rate was 170; This spontaneous case was reported by a patient and describes the occurrence of HYPERTENSION (blood pressure was 139/85) and TACHYCARDIA (heart rate went up to 120 /5 times within an hour/heart rate was 170) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient was tested positive for covid-19) on 10-Feb-2021 and Heart rate increased (After he got COVID, he had a similar alert that his heart rate went up.). Concurrent medical conditions included Diabetes (Start Date: about 10 years ago. Recent change in status such as improvement or worsening: none).   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2022, the patient experienced TACHYCARDIA (heart rate went up to 120 /5 times within an hour/heart rate was 170). On 24-May-2022, the patient experienced HYPERTENSION (blood pressure was 139/85). The patient was treated with METOPROLOL SUCCINATE for Heart rate increased, at a dose of 50 milligram once a day. On 19-May-2022, TACHYCARDIA (heart rate went up to 120 /5 times within an hour/heart rate was 170) had resolved. At the time of the report, HYPERTENSION (blood pressure was 139/85) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-May-2022, Electrocardiogram: 170 (High) 170. On 24-May-2022, Blood pressure measurement: 139/85 (High) 139/85. On an unknown date, Heart rate: 120 (High) 120.         No allergies were provided by the reporter. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Concomitant product use was not provided by the reporter.  Patient has an apple watch, which monitors his heart beat. He was sitting watching TV and his heart rate went up to 120. It happened 5 times within an hour. His heart rate should be at 100. He went to the ER, they did an EKG. His heart rate was 170 at the ER. They gave him medicine to slow down the heart rate. He stabilized in 4 hours back to normal. This was on 19-May-2022, the next day after the Moderna injection. His blood pressure was 139/85 last night 24-May-2022. He looked it up online, and it said it was pre-hypertensive.
Pt. developed a rash 6/23/2022 which was for days after receiving the Shingles vaccine. She developed a vesicular type rash around the back of her neck and shoulders which persisted a few days. States the rash became severely pruritic and now she can't stop scratching.
CHILLS; FEVER; BODY ACHE/PAIN; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-APR-2021 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 07-APR-2021, the subject experienced body ache/pain. On 07-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and had not recovered from body ache/pain, and chills. This report was non-serious.
Malaise, fever 100 degrees, myalgias, bilateral headache, stiff neck, positive kerning sign.
Started to feel hot and "body on fire" 20 minutes post vaccination. Placed in supine position for about 10 minutes. Ice pack to chest and back of neck. Sat up, rechecked vital signs, Gave granola bar and powerade. Rechecked all vitals signs, Monitored an additional 30 minutes. Felt better and released to home.
Patient received second dose of Modern vaccine on 4.22 but had received Hepatitis B vaccine on 4.15.21-before the open window period.
Dibilitating pain from injection site down arm and forearm to fingers and along shoulder to right side of neck up to right ear. Seems to be getting worse with time.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Sep2022 at 11:00 as dose 5 (booster), single (Lot number: Gh9703) at the age of 66 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 18Feb2021 at 00:30 as dose 1, single (Lot number: EN6200), in right arm, on 11Mar2021 at 09:00 as dose 2, single (Lot number: EN6206), in right arm, on 01Oct2021 at 13:00 as dose 3 (booster), single (Lot number: 30155BA), in right arm and on 01Apr2022 at 12:00 as dose 4 (booster), single (Lot number: Fk9895), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroid" (unspecified if ongoing); "mitral valve prolapse" (unspecified if ongoing); "perennial vasomotor rhinitis" (unspecified if ongoing); "asthma" (unspecified if ongoing); "Sulfa drugs" (unspecified if ongoing). Concomitant medication(s) included: ATENOLOL (ongoing); LEVOTHYROXINE (ongoing); QVAR; PROLIA (ongoing). The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Nov2022, outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (23Nov2022) Positive; (19Nov2022) Negative, notes: after completing the pills and stayed negative; (20Nov2022) Negative, notes: after completing the pills and stayed negative; (21Nov2022) Negative, notes: after completing the pills and stayed negative; (22Nov2022) Negative, notes: after completing the pills and stayed negative; (23Nov2022) Positive, notes: until 23Nov when symptoms returned and I tested positive again. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Dose given was 1 hour and 20 minutes outside of the 6 hour limit on an open vial of Moderna
knew his shoulder was going to be sore; at the injection site he has a line the size of little finger and it looks jaundice - yellow/green color; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (at the injection site he has a line the size of little finger and it looks jaundice - yellow/green color) and ARTHRALGIA (knew his shoulder was going to be sore) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (at the injection site he has a line the size of little finger and it looks jaundice - yellow/green color). On an unknown date, the patient experienced ARTHRALGIA (knew his shoulder was going to be sore). At the time of the report, VACCINATION SITE DISCOLOURATION (at the injection site he has a line the size of little finger and it looks jaundice - yellow/green color) and ARTHRALGIA (knew his shoulder was going to be sore) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-092495 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-092495:Same reporter, different patient
seen on 8JUL93 for arm abrasion & given DTP/OPV booster; devel fever 5 hrs p/vax; 12 hrs p/went to 104; w/neck stiffness; on way to ER for eval eyes rolled upward drooling of mouth, stiffened, tonic clonic movements of legs x 5 mins;
ON 01/18/2021, 6 DAYS AFTER INJECTION ON 01/12/2021, I BEGAN TO DEVELOPE AN ITCHY, RED RASH AROUND THE INJECTION SITE ON MY LEFT ARM.  AS OF THIS DAY IT CONTINUES TO GAIN IN SIZE, ALTHOUGH BECOMING LESS RED IN COLOR TOWARDS THE CENTER.  AS OF THIS DATE, IT MEASURES APPROX. 5" L X 3"W.   DOCTORS PRESCRIBED Z-PACK IN CASE OF INFECTION, PREDNISONE, DESOXIMETASONE USP CREAM, AND BENADRYL REGIMENT.
10/26/15 tinnitus - referred to ENT. Burning in feet - started gabapentin 100mg. Joint pain. Patient words: coughing x 1 week ringing in ears and irritates me feet burn at night-visit 1 month ago was for blood in the urine. Note finished CIPRO-culture was neg-has not seen anymore blood. The patient is a 66 year old female who presents for a recheck of Diabetes. The patient was most recently seen 1 month ago. The patient checks their glucose never. Patient words: She went out to shovel some snow-moved get in firewood Sat-Sun with pain. Took ADVIL. The patient is a 66 year old female who presents with joint pain. Symptoms include joint pain and joint swelling. Symptoms are located in the neck, lower back, right knee and right foot. The patient describes the pain as aching. The patient describes this as worsening. Associated symptoms include muscle weakness. Current treatment includes non steroidal anti-inflammatory drugs.
Onset (10-26-17 - 10-27-17) 5PM approx.-severe cramps in legs (Both legs) all PM and AM through hrs and night until early AM. eased somewhat. Told husband I must see Dr.-Was told she was could not see me. I called back-got a recording-2 or 3x's-left message to please somebody call back-no call back. Husband took me to ER approx 8 AM (10-27-17)-saw Dr on call-MRI of head and lab work (blood and urine spec-all WNL's). Dx'd with muscle cramps-Vision still affected.
patient called said she has redness and rash going down from the site of administration, warm to the touch measuring about 3 x 2 in.  provider notified. redness did start to spread.  Information passed on to provider
DVT of unknown etiology (minimal risk factors and no acute stimuli), PE likely originating from DVT, Afib probably arising from PE but perhaps preceding it, uncontrolled hypertension that has taken substantially increased medication to bring back under control.
Headache, Myalgia, Arthralgia, Soreness, bruising, chills, fatrigue Narrative:  Other Relevant History:
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider at a healthcare facility recommended and or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 11-APR-2016, the patient's health care provider (unspecified healthcare professional) administered the ZOSTAVAX (lot number, dosage and route of administration not provided) to the patient. On or about 10-NOV-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (not further specified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Morbilliform rash on trunk developed two days after receiving H1N1 vaccine. Had some flu-like sx 36 hrs after vaccine, then developed rash 60 hrs after vaccine.
Moderna vaccine given at age 17.  No medical reactions noted.  Boost dose given 4/27/21.  Parent is aware.
Immediately after receiving vaccine patient said she did not feel well, felt dizzy, lips pale, became disoriented with eyes closed. This lasted for 5-10 seconds before she responded to her name. Placed supine. Gradually back to baseline in about 10 minutes. Monitored in clinic for 45 minutes left independently. Vasovagal syncope secondary to vaccine procedure.
Headache--two-and-a-half days; diarrhea, abdominal discomfort--a few hours; fever--one day (100.5 degrees).
Student c/o of rash above wrist left inner arm approximately 1 hour after immunizations (TDAP) upon returning to room 324. Benadryl 5mg IM at 300 PM. 300 PM - father came for student at 330PM student sleepy. Later stated chest pains while playing basketball. BP 90/60 mmgh, P 96 min 300 PM.
After the vaccination, she started feeling dizzy. When she woke the next morning she had hives on her face and lips and chest. Her lips and tongue was swollen and dark. She started feeling itchy in her throat and constricted, chest tightness and stomach pain. Ever since the vaccination, she breaks to to hives on and off. And joint pains, extreme fatigue and migraines. She was referred to Rheumatologist and Immunologist.
was diagnosed with unspecified precancerous cells of the cervix; This spontaneous report was received from a patient's mother via company representative and refers to a currently 24-year-old female patient. The patient concurrent conditions, medical history and concomitant medications were not reported.   On unspecified date in 2011, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (anatomical location, route of administration, lot # and expiry date were not reported) for prophylaxis. On unspecified dates in 2011, she received the second, and the third dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (anatomical location, route of administration, lot # and expiry date were not reported) for prophylaxis. On an unknown date, the patient was diagnosed with unspecified precancerous cells of the cervix. The patient sought medical attention, and on unspecified date, she had an outpatient Loop Electrosurgical Excision Procedure (LEEP), as a treatment of the event. On 20-DEC-2019, she had an unspecified outpatient surgery.   The outcome of the event and the causality assessment were not reported.
On Saturday April 17th I woke up at 6 in the morning with sever vertigo. I was extremely sick and could not stand up straight. Room was spinning and I got sick with diarrhea. Was extremely nauseous and the feeling only passed when I was lying down. Eventually the severe symptoms subsided after 2.5 hours and  I was able to mostly function with the use of motion bands on my wrist. It was so scary, I paid 200 to rejoin One Medical Group and booked a same day in person appointment. The doctor said my ears were inflamed and did the Epley manuever with me. However, the symptoms are still lingering.I'm dizzy and my ears feel clogged. I can't seem to get them unplugged. It still feels at times as if the room is spinning around me and I'm woozy in a bit of a brain fog. I've been keeping the motion bands on at most times to try to keep the symptoms at bay.
I never took it again and been fine; Initial information received on 25-Oct-2020 regarding an unsolicited non-valid non-serious case received from a consumer/non-health care professional.  This case involves patient of unknown age who never took it again and been fine (patient dissatisfaction with device) while she received influenza vaccine .  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect vaccine at an unknown dose produced by unknown manufacturer lot number not reported via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date (latency unknown) after the suspect vaccine initiation the patient never took it again and been fine (patient dissatisfaction with device).  Laboratory details were not reported. Action taken was not applicable.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown.  There will be no information available on the batch number for this case.
This spontaneous report as received from a health care worker (office manager) refers to an unspecified amount of patients of unknown age. On unknown dates the patients were vaccinated with M-M-R II (lot # J010993, expire dates 06-SEP-2015) (dose and route not reported). The office manager stated this temperature excursion was supported and the vaccines were out of range for approximately 3 hours. This is one of several reports received from the same source. Additional information has been requested.
Hard, red and warm induration at injection site;  mom states patient very uncomfortable d/t pain
This spontaneous report was received from a registered nurse refers to an unspecified number of patients (no patient's information were provided). On unknown date the patients were vaccinated with GARDASIL, that were improperly stored outside the recommended temperature storage range. No adverse effects reported. Additional information is not expected.
12/30-Initially the patient did not have any reactions the day of the vaccine. Patient called  the day following the vaccine 12/31 with c/o dizziness/lightheaded/and extremely nauseated.
1st dose 5 years ago, did not receive 2nd dose; Shingles in 2021; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 88-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On 1st July 2021, more than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not reported for the 1st dose and the age at vaccination was not applicable for the 2nd dose. The patient received 1st dose of Shingrix, 5 years ago from the date of reporting.  After receiving 1st dose of Shingrix, the patient had a case of shingles, which was lasted 2 weeks and had resolved. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, as she was not told there was a 2nd dose, which led to incomplete vaccination schedule. Information was provided as per content and product information, referred to health care professional and provided medical advice disclaimer. The reporter consented to follow up. Note: received 1st dose in 2017 when it was newly launched.
Pain and swelling in left elbow, 3-7 days post vaccination.  Limitation of motion.  Unable to write.  Recurrent polyarthralgias over last 7 months.  Now right shoulder effected.
3RD DOSE OF SHINGRIX GIVEN BY MISTAKE. PATIENT IS FINE WITH NO ISSUES. CALLED MANUFACTURER AND PER MANUFACTURER, PATIENT SHOULD HAVE NO ISSUES OTHER THAN NORMAL SIDE EFFECTS. PATIENT AND PATIENT'S DOCTOR ARE AWARE OF 3RD DOSE GIVEN.
Patient states she has been having vertigo since receiving the vaccine. She has to walk with a walker at times due to the vertigo. First vaccine received 1/24/2021
This spontaneous report as received from a pharmacist refers to a 64 year old patient of unknown gender. Patients concurrent conditions included rheumatoid arthritis. History of drug allergies/reactions was  none. On 26-AUG-2014 the patient was vaccinated with ZOSTAVAX 19400 PFU (dose and frequency unknown) (lot number K003597 with expiry date of 12-MAY-2015). Concomitant therapies included diazepam, pravastatin sodium and hydrochlorothiazide (manufacturer unknown). The pharmacist reported that the patient developed rash after receiving ZOSTAVAX on 26-AUG-2014. No treatment was provided for event. Patient sought medical attention by calling pharmacist. The outcome of rash was reported as not recovered/not resolved. The causality of the events with ZOSTAVAX was not reported. Additional information has been requested.
Patient reports swollen glands, severe sore throat and other flu-like symptoms. 7 days after injection patient developed a round area of redness and heat about 2 inches in diameter at the injection site, along with tenderness at site.
Patient received second dose of Pfizer vaccine.  Vaccine expiration time 0930 on 5/12/2021. Patient received vaccine on 5/12/2021 at 0932. MD made aware.  No harm to patient or adverse reactions.
Two days after receiving injection I developed a severe ulceration in the roof of my mouth. I didnt associate the two until I sent an email to all the other 45 employees who had also received it and 7 others had experienced either fever blisters or mouth ulcers 2-3 days after injection. It has been 4 days and ulcer is no bette.
Temperature measured  as 101 degrees fahrenheit at approximately 1pm on 7/14. Head was hot to touch all day  on 7/14. I had to lie down for most of the day and found simple activities difficult. I felt weak and disorientated. I also appeared to develop a rash on my lower stomach with multiple red bumps. My temperature today 7/15/2022 at 9:43 am is  99.3 Fahrenheit.
Constipation; large amount of stool volume within colon.  Pain on left side that started week and 1/2 prior to 11/27.
I received this shot on 8/17/12 Lot number AC52B081BA exp 2/15/2014. Thursday, August 23 2012, 2 AM, I woke up with joint aching, fever and severe headache.  I started taking 600mg of Advil every 4-5 hours with relief. This continued thru Friday, so I called the pharmacist and she recommend I visit the clinic. West Nile Virus is in this area, so we were concerned that my symptoms of 6-7 days later may not be due to the shot.  I visited the clinic and had labs drawn- WNV was negative, CBC normal. I continued to depend on the Advil and started developing nausea Friday, waking up to diarrhea on Saturday.  Major fatigue and weakness. It took me thru Tuesday to be back to normal. My bowels are still very loose. Energy is back and headache is gone.
Onset with extreme muscle weakness, later extreme achiness.  At first just upper body symptoms then eventually his whole body. His mouth started tingling and he had extreme nausea.  Finally went to ER about 2pm. Patient says he suffered for about 2 hours before finally going to the ER.